Cellular tests in the diagnosis of drug hypersensitivity

Current Pharmaceutical Design

Volumn 14, Issue 27, 2008, Pages 2803-2808

  Sanz, María L ^a,c   Gamboa, Pedro M ^b   De Weck, A L ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b HOSPITAL DE BASURTO   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Basophil activation test; Betalactam allergy; CD63; Cellular tests; Drug allergy diagnosis; NSAID hypersensitivity; Sulphidoleukotrienes

Indexed keywords

ACETYLSALICYLIC ACID; BETA LACTAM ANTIBIOTIC; CD69 ANTIGEN; IMMUNOGLOBULIN E; INTERLEUKIN 3; MUSCLE RELAXANT AGENT; NEUROMUSCULAR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PYRAZOLONE; ROCURONIUM;

ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; BASOPHIL ACTIVATION TEST; CROSS REACTION; DRUG HYPERSENSITIVITY; HISTAMINE RELEASE; HUMAN; IMMUNE FUNCTION TEST; LEUKOCYTE ACTIVATION; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SEROLOGY; SKIN TEST;

ANIMALS; BASOPHIL DEGRANULATION TEST; BASOPHILS; DRUG HYPERSENSITIVITY; FLOW CYTOMETRY; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 65949093284     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208786369722     Document Type: Review

References (87)

1. Schleimer RP, Fox CC, Togias A, Norman P, Lichtenstein LM. Role of human basophils and mast cells in the pathogenesis of allergic diseases. J Allergy Clin Immunol 1985; 76: 369-74.
2. Ebo DG, Sainte-Laudy J, Bridts CH, Mertens CH, Hagendorens MM, Schuerwegh AJ, et al. Flow-assisted allergy diagnosis: Current applications and future perspectives. Allergy 2006; 61: 1028-39.
3. Crockard AD, Ennis M. Laboratory-based allergy diagnosis: Should we go with the flow? Clin Exp Allergy 2001; 31: 975-7.
4. Sanz ML, Maselli JP, Gamboa PM, Garcia-Aviles MC, Oehling A, Diéguez I, et al. Flow-cytometric basophil activation test: A review. J Investig Allergol Clin Immunol 2002; 12: 143-54.
5. De Weck AL, Sanz ML. Flow cytometric Cellular Allergen Stimulation Test (FAST/Flow CAST): Technical and clinical evaluation of a new diagnostic test in allergy and pseudo-allergy. ACI International 2002; 14: 204-15.
6. Ebo DG, Hagendorens MM, Bridts CH, Schuerwegh AJ, De Clerk LD, Stevens WJ. In vitro allergy diagnosis: Should we follow the flow? Clin Exp Allergy 2004; 34: 332-9.
7. Boumiza R, Monneret G, Forissier MF, Savoye J, Gutowski MC, Powell WS, et al. Marked improvement of the basophil activation test by detecting CD203c instead of CD63. Clin Exp Allergy 2003; 33: 849-52.
8. Boumiza R, Debard AL, Monneret G. The basophil activation test by flow cytometry: Recent developments in clinical studies, standardization and emerging perspectives. Clin Mol Allergy 2005; 3: 9.
9. Sanz ML, Gamboa PM. De Weck AL. In vitro tests: Basophil activation tests. In Pichler W, Ed. Drug Hypersensitivity. Karger: Basel 2007: 389-400.
10. De Weck AL, Sanz ML, Gamboa PM, Aberer W, Bienvenu J, Blanca M, et al. Diagnostic tests based on human basophils: More potentials and perspectives than pitfalls. Int Arch Allergy Immunol 2008; 146: 177-89.
11. Gane P, Pecquet C, Lambin P, Abuaf N, Leynadier F. Flow cytometry evaluation of human basophils. Cytometry 1993; 14: 344-8.
12. Bochner BS, Sterbinski SA. Altered surface expression of CD11 and Leu 8 during human basophil degranulation. J Immunol 1991; 146: 2367-73.
13. Stallman PJ, Aalberse RC. Estimation of basophil-bound IgE by quantitative immunofluorescence microscopy. Int Arch Allergy Appl Immunol 1977; 54: 9-18.
14. Ebo DG, Dombrecht EJ, Bridts CH, Aerts NE, de Clerck LS, Stevens WJ. Combined analysis of intracellular signalling and immunophenotype of human peripheral blood basophils by flow cytometry: A proof of concept. Clin Exp Allergy 2007; 37: 1668-75.
15. Moneret-Vautrin DA, Sainte Laudy J, Kanny J, Fremont S. Human basophil activation measured by CD63 expresion and LTC4 release in IgE-mediated food allergy. Ann Allergy Asthma Immmunol 1999; 82: 33-40.
16. Sabbah A, Plassais R, Grenapin S, Drouet M, Lauret MG, Loiry M, Sainte-Laudy J. Testing basophil activation by flow cytometry in the diagnosis of allergy to hymenopteran venom. Allerg Immunol (Paris) 1998; 30: 44-8.
17. Sanz ML, Sánchez G, Vila L, Uasuf C, Chazot M, Diéguez I, et al. Ag-induced basophil activation: CD63 cell expression detected by flow cytometry in patients allergic to Dermatophagoides pteronyssinus and Lolium perenne. Clin Exp Allergy 2001; 31: 1-8.
18. De Weck AL, Sanz ML, Gamboa PM, Aberer W, Bienvenu J, Blanca M, et al. Diagnostic tests based on human basophils: More potentials and perspectives than pitfalls. II. Technical issues. J Investig Allergol Clin Immunol 2008; 18: 143-55.
19. Kleine-Tebbe J, Erdmann S, Knol EF, Macglashan DW Jr, Poulsen KL, Gibbs BF. Diagnostic tests based on human basophils: Potentials, pitfalls and perspectives. Int Arch Allergy Immunol 2006; 141: 79-90.
20. Pâris-Köhler A, Demoly P, Persi L, Lebel B, Bousquet J, Arnoux B. In vitro diagnosis of cypress pollen allergy by using cytofluorometric analysis of basophils (Basotest). J Allergy Clin Immunol 2000; 105: 339-45.
21. Saporta M, Kamei S, Persi L, Bousquet J, Arnoux B. Basophil activation during pollen season in patients monosensitized to grass pollens. Allergy 2001; 56: 442-5.
22. Sainte-Laudy J, Sabbah A, Drouet M, Lauret MG, Loiri M. Diagnosis of venom allergy by flow cytometry. Correlation with clinical history, skin tests, specific IgE, histamine and leukotriene C4 release. Clin Exp Allergy 2000; 30: 1166-71.
23. Sanz ML, Gamboa PM, Garcia-Aviles C, Vila L, Dieguez I, Antepara I, et al. Flow-cytometric cellular allergen stimulation test in latex allergy. Int Arch Allergy Immunol 2003; 130: 33-9.
24. Sanz ML, García-Avilés MC, Gamboa PM, Maselli JP, Diéguez I, De Weck AL. The use of a Flowcytometric basophil activation test (FAST) for the in vitro diagnosis of latex allergy. J Allergy Clin Immunol 2002; 109: (abstr 869).
25. Ebo DG, Lechkar B, Schuerwegh AJ, Bridts CH, De Clerck LS, Stevens WJ. Validation of a two-color flow cytometric assay detecting in vitro basophil activation for the diagnosis of IgE-mediated natural rubber latex allergy. Allergy 2002; 57: 706-12.
26. Abuaf N, Rajoely B, Ghazouani E, Levy DA, Pecquet C, Chabane H, et al. Validation of flow cytometry assay detecting in vitro basophil activation for the diagnosis of muscle relaxant allergy. J Allergy Clin Immunol 1999; 104: 411-8.
27. Monneret G, Benoit Y, Debard AL, Gutowski MC, Topenot I, Bienvenu J. Monitoring of basophil activation using CD63 and CCR3 in allergy to muscle relaxant drugs. Clin Immunol 2002; 102: 192-9.
28. Torres MJ, Padial, Mayorga C, Fernandez T, Sanchez-Sebate E, Cornejo-Garcia JA, et al. The diagnostic interpretation of basophil activation test in immediate allergic reactions to betalactams. Clin Exp Allergy 2004; 34: 1768-75.
29. Sanz ML, Gamboa PM, Antépara I, Uasuf C, Vila L, Garcia-Aviles C, et al. Flow-cytometric basophil activation test by detection of CD63 expression in patients with immedate type reactions to Betalactam antibiotics. Clin Exp Allergy 2002; 32: 277-86.
30. Sanz ML, De Weck AL, Uasuf C, Gamboa PM, Chazot M. Use of flow cytometry to assess basophil activation in patients allergic to betalactam antibiotics. Correlation between Flow cytometric Alergen Stimulation Test (FAST) and other in vivo and in vitro tests. Int Arch Allergy Immunol 2001, 124: 307-8.
31. Sabbah A, Sainte-Laudy J, Drouet M, Lauret MG, Loiry M. Anaphylactic or anaphylactoid reactions to paracetamol. Report of 3 cases. Allerg Immunol (Paris) 1997; 29: 60-2.
32. Sanz ML, Gamboa PM, De Weck AL. A new combined test with flowcytometric basophil activation and determination of sulfidoleukotrienes is useful for in vitro diagnosis of hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs. Int Arch Allergy Immunol 2005; 136: 58-72.
33. Gamboa PM, Sanz ML, Caballero MR, Urrutia I, Antépara I, Esparza R, et al. The flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome. Clin Exp Allergy 2004; 34: 1448-57.
34. Sanz ML, García-Avilés MC, Tabar AI, Anda M, García BE, Barber D, et al. Basophil Activation Test and specific IgE measurements using a panel of recombinant natural rubber latex allergens to determine the latex allergen sensitization profile in children. Pediatr Allergy Immunol 2006; 17: 148-56.
35. Gamboa PM, Cáceres O, Antépara I, Sánchez-Monge R, Ahrazem O, Salcedo G, et al. Two different profiles of peach allergy in the north of Spain. Allergy 2007; 62: 408-14.
36. Erdmann SM, Sachs B, Kwiecien R, Moll-Slodowy S, Sauer I, Merk HF. The basophil activation test in wasp venom allergy: Sensitivity, specificity and monitoring specific immunotherapy. Allergy 2004; 59: 1102-9.
37. Ebo DG, Hagendorens MM, Bridts CH, Schuerwegh AJ, De Clerck LS, Stevens WJ. Flow cytometric analysis of in vitro activated basophils, specific IgE and skin tests in the diagnosis of pollen-associated food allergy. Cytometry B Clin Cytom 2005; 64: 28-33.
38. Garcia-Aviles C, Sanchez-Lopez G, Sanz ML, Uasuf C, Dieguez I, Chazot M, et al. Flow cytometric Allergen Stimulation Test (FAST) in the in vitro diagnosis of food allergy. Allergy 2000; 55 (Suppl.63): 128.
39. Wedi B, Novacovic V, Koerner M, Kapp A. Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression-inhibitory effects of anti-inflammatory drugs. J Allergy Clin Immunol 2000; 105: 552-60.
40. Gyimesi E, Sipka S, Danko K, Kiss E, Hidvegi B, Gal M, et al. Basophil CD63 expression assay on highly sensitized atopic donor leucocytes. A useful method in chronic autoimmune urticaria. Br J Dermatol 2004; 151: 288-96.
41. De Swerdt A, Van Den Keybus C, Kasran A, Cadot P, Neyens K, Coorevits L, et al. Detection of basophil-activating IgG autoantibodies in chronic idiopathic urticaria by induction of CD63. J Allergy Clin Immunol 2005; 116: 662-7.
42. Frezzolini A, Provini A, Teofoli P, Pomponi D, De Pita O. Serum-induced basophil CD63 expression by means of a tricolour flow cytometric method for the in vitro diagnosis of chronic urticaria. Allergy 2006; 61: 1071-7.
43. Grattan CEH, Walpole D, Francis DM, Niimi DM, Dooston G, Edler S, et al. Flow cytometric analysis of basophil numbers in chronic urticaria: Basopenia is related to serum histamine releasing activity. Clin Exp Allergy 1997; 27: 1417-24.
44. Szegedi A, Irinyi B, Gal M, Hunyadi J, Danko K, Kiss E, et al. Significant correlation between the CD63 assay and the histamine release assay in chronic urticaria. Br J Dermatol 2006; 155: 67-75.
45. Vasagar K, Vonakis BM, Gober LM, Viksman A, Gibbons SP Jr, Saini SS. Evidence of in vivo basophil activation in chronic urticaria. Clin Exp Allergy 2006; 36: 770-6.
46. Sainte-Laudy J, Vallon C, Guérin JC. Analysis of membrane expression of the CD63 human basophil activation marker. Applications to allergologic diagnosis. Allerg Immunol (Paris) 1994; 26: 211-4.
47. Sanz ML, Gamboa PM, Uasuf C, Vila L, Garcia-Aviles C, Chazot M, et al. Flow-cytometric basophil activation test by detection of CD63 expression in patients with immedate type reactions to betalactam antibiotics. Clin Exp Allergy 2002; 32: 277-86.
48. De Weck AL, Gamboa PM, Sanz ML. Clinical evaluation of in vitro tests in diagnosis of immediate allergic reactions to Betalactam antibiotics. ACI Int 2002; 14: 185-92.
49. Sainte-Laudy J, Le Provost A, André C, Vallon C. Comparison of four methods for human basophil activation measurement: Alcian blue staining, histamine and LTC4 release and flow cytometry. In: Basomba A, Hernadez MD, De Rojas F Eds, Proceedings of the 16th EAACI Congress 1995; 257-60.
50. Gamboa PM, Sanz ML, Caballero MR, Antepara I, Urrutia I, Jauregui I, et al. Use of CD63 expression as a marker of in vitro basophil activation and leukotriene determination in metamizol allergic patients. Allergy 2003; 58: 312-7.
51. MacGlashan DW Jr, Peters SP, Warner J, Lichtenstein LM. Characteristics of human basophil sulfidoleukotriene release: Releasability defined as the ability of the basophil to respond to dimeric cross-links. J Immunol 1986; 136: 2231-9.
52. MacGlashan DW Jr, Warner J. Stimulus-dependent leukotriene release from human basophils: A comparative study of C5a and Fmet-leu-phe. J Leukoc Biol 1991; 49: 20-40.
53. Miura K, Schroeder JT, Hubbard WC, MacGlashan DW Jr. Extracellular signal-regulated kinases regulate leukotriene C4 generation, but no histamine release or IL-4 production from human basophils. J Immunol 1999; 162: 4198-206.
54. Miura K, Lavens-Philipps S, MacGlashan DW Jr. Localizing a control region in the pathway to leukotriene C(4) secreetion following stimulation of human basophils with anti-IgE antibody. J Immunol 2001; 167: 7027-37.
55. MacGlashan DW Jr. IgE and Fcepsilon R1 regulation. NY Acad Sci 2005; 1050: 73-88.
56. Knol EF, Koendeman L, Mul FP, Verhoeven AJ, Roos D. Differential activation of human basophils by anti-IgE and formyl-methionyl-leucyl-phenylalanine. Indications for protein kinase C-dependent and independent activation pathways. Eur J Immunol 1991; 21: 881-5.
57. Dahinden CA, Kurimoto J, Baggiolini M, Dewald B, Walz A. Histamine and sulfidoleukotriene release from human basophils: Different effects of antigen, anti-IgE, C5a, f-Met-Leu-Phe and the novel neutrophil-activating peptide NAF. Int Arch Allergy Appl Immunol 1989; 90: 113-8.
58. Kurimoto Y, De Weck AL, Dahinden CA. The effect of interleukin 3 upon IgE-dependent and IgE-independent basophil degranulation and leukotriene generation. Eur J Immunol 1991; 21: 361-8.
59. Leynadier F, Rajoely B, Ghazouani E, Pecquet, C, Abuaf N. The diagnosis of anaphylactic reactions to muscle relaxants by flow cytometry. J Allergy Clin Immunol 1996; 97: 344.
60. Sudheer PS, Hall JE, Read GF, Rowbottom AW, Williams PE. Flow cytometric investigation of peri-anaesthetic anaphylaxis using CD63 and CD203c. Anaesthesia 2005; 60: 251-6.
61. Kvedariene V, Kamey S, Ryckwaert Y, Rongier M, Bousquet J, Demoly P, et al. Diagnosis of neuromuscular blocking agent hypersensitivity reactions using cytofluorimetric analysis of basophils. Allergy 2006; 61: 311-5.
62. Ebo DG, Bridts CH, Hagendorens MM, Mertens CH, De Clerck LS, Stevens WJ. Flow-assisted diagnostic management of anaphylaxis from rocuronium bromide. Allergy 2006; 61: 935-9.
63. Gamboa PM, García-Avilés MC, Urrutia I, Antepara I, Esparza R, Sanz ML. Basophil activation and sulfidoleukotriene production in patients with immediate allergy to betalactam antibiotics and negative skin tests. J Investig Allergol Clin Immunol 2004; 14: 278-83.
64. De Weck AL, Sanz ML. Cellular allergen stimulation test (CAST) 2003, a review. J Investig Allergol Clin Immunol 2004; 14: 253-73.
65. De Weck AL, Sanz ML, Gamboa PM. Further considerations on the mechanism of NSAID hypersensitivity. In: Ring J, Holgate S, Kay B, Eds. Cellular and molecular targets in allergy and clinical immunology. Proceeding of the 26th symposium of the CIA Symposium. Göttingen: Hogrefe & Huber 297-300.
66. De Weck AL, Gamboa PM, Esparza B, Sanz ML. Hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs). Curr Pharm Des 2006; 12: 3347-58.
67. Sainte-Laudy J. Nine cases of suspected IgE-mediated anaphylaxis induced by aspirin. Allergy Clin Immunol Int 2002; 14: 220-2.
68. Malbran A, Yeyati E, Rey GL, Galassi N. Diclofenac induces basophil degranulation without increasing CD63 expression in sensitive patients. Clin Exp Immunol 2007; 147: 99-105.
69. Le Pabic F, Sainte Laudy J, Blanchard N, Moneret-Vautrin DA. First case of anaphylaxis to iodinated povidone. Allergy 2003; 58: 826-7.
70. Gamboa PM, Sanz ML, Urrutia I, Jauregui I, Antepara I, Dieguez I, et al. CD63 expression by flow cytometry in the in vitro diagnosis of allergy to omeprazole. Allergy 2003; 58: 538-9.
71. Ebo DG, Goossens S, Opsomer F, Bridts CH, Stevens WJ. Flow-assisted diagnosis of anaphylaxis to hyaluronidase. Allergy 2005; 60: 1333-4
72. Bauer C, Opple T, Rueff F, Przybilla B. Anaphylaxis to viscotoxins of mistletoe (Viscum album) extracts. Ann Allergy Asthma Immunol 2005; 94: 86-9.
73. Apostolou E, Deckert K, Puy R, Sandrini A, de Leon MP, Douglass JA, et al. Anaphylaxis to Gelofusine confirmed by in vitro basophil activation test: A case series. Anaesthesia 2006; 61: 264-8
74. Shields MD, Mirakhur RK, Crockard AD, Edfar GD. The use of basophil activation to diagnose allergy to Gelofusine. Anesthesia 2006; 61: 716-7.
75. Ebo DG, Bridts CH, Stevens WJ. Anaphylaxis to an urethral lubricant: chlorhexidin as the "hidden" allergen. Acta Clin Belg 2004; 59: 358-60.
76. Ebo DG, Bridts CH, Stevens WJ. IgE-mediated anaphylaxis from chlorhexidine: Diagnostic possibilities. Contact Dermatitis 2006; 55: 301-2.
77. Ebo DG, Schuerwegh A, Stevens WJ. Anaphylaxis to starch. Allergy 2005; 55: 1098-9.
78. Ebo DG, Wets RD, Spiessen TK, Bridts CH, Stevens WJ. Flow-assisted diagnosis of anaphylaxis to patent blue. Allergy 2005; 60: 703-4.
79. Scherer K, Studer W, Figueiredo V, Bircher AJ. Anaphylaxis to isosulfan blue and cross-reactivity to patent blue V: A case report and review of the nomenclature of vital blue dyes. Ann Allergy Asthma Immunol 2006; 96: 497-500.
80. Caceres Calle O, Fernandez-Benitez M. Allergy to dexchlorpheniramine. Study of a case. Allergol Immunopathol (Madr) 2004; 32: 306-9.
81. Orta M, Ordoqui E, Aranzabal A, Fernandez C, Bartolomé B, Sanz ML. Anaphylactic reaction after artificial insemination. Ann Allergy Asthma Immunol 2003; 90: 446-51.
82. Ebo DG, Bridts CH, Stevens WJ. IgE-mediated large local reaction from recombinant hepatitis B vaccine. Allergy 2008; 63: 483-4.
83. Mari A. IgE to cross-reactive carbohydrate determinants: Analysis of the distribution and appraisal of the in vivo and in vitro reactivity. Int Arch Allergy Immunol 2002; 129: 286-95.
84. Nopp A, Johansson SG, Ankerst J, Bylin G, Cardell LO, Gronneberg R, et al. Basophil allergen threshold sensitivity, a useful approach to anti-IgE treatment efficacy evaluation. Allergy 2006; 61: 298-302
85. Fylaktakidou KC, Hadjipavlou-Litina DJ, Litinas KE, Varella EA, Nicolaides DN. Recent developments in the chemistry and in the biological applications of amidoximes. Curr Pharm Des 2008; 14(10): 1001-47.
86. Isolauri E, Kalliomaki M, Laitinen K, Salminen S. Modulation of the maturing gut barrier and microbiota: A novel target in allergic disease. Curr Pharm Des 2008; 14(14): 1368-75.
87. Kanduc D. Correlating low-similarity peptide sequences and allergenic epitopes. Curr Pharm Des 2008; 14(3): 289-95.